Explore the details of the Pfizer Inc. V. Apotex, Inc. case under case number 1:24-cv-00621 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00621
Filing Date
May 23, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Apotex Corp. -
Apotex, Inc. -
Pfizer Ireland Pharmaceutials -
Bristol-Myers Squibb Company -

Patents Involved in the Case

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US8759372B2
-US8314117B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 2, 2025SO ORDERED, re 101 STIPULATION TO EXTEND TIME for the parties to exchange and finalize search terms pursuant to the ESI Order (D.I. 43) to June 13, 2025, filed by Pfizer Inc., Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company. Signed by Judge Colm F. Connolly on 6/2/2025. (kmd) (Entered: 06/02/2025)PACER Document
Jun 3, 2025NOTICE OF SERVICE of Plaintiffs' Initial Proposed Constructions and Intrinsic Support filed by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company.(Dellinger, Megan) (Entered: 06/03/2025)PACER Document
Jun 3, 2025NOTICE OF SERVICE of Defendants' Proposed Constructions and Supporting Intrinsic Evidence filed by Changzhou Pharmaceutical Factory.(Taylor, Daniel) (Entered: 06/03/2025)PACER Document
Jun 10, 2025NOTICE OF SERVICE of Plaintiffs' Initial Rebuttal Intrinsic Support filed by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company.(Dellinger, Megan)PACER Document
Jun 10, 2025NOTICE OF SERVICE of Defendants' Proposed Constructions and Supporting and Rebuttal Intrinsic Evidence filed by Changzhou Pharmaceutical Factory.(Taylor, Daniel)PACER Document
Jun 11, 2025MOTION for Pro Hac Vice Appearance of Attorney Kevin Georgek and Samantha Kokonis - filed by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company. (Dellinger, Megan)PACER Document
Jun 11, 2025Pro Hac Vice Fee - Credit Card Payment received for Kevin Georgek and Samantha Kokonis. ( re [107] MOTION for Pro Hac Vice Appearance of Attorney Kevin Georgek and Samantha Kokonis )( Payment of $ 100, receipt number ADEDC-4708574).(Dellinger, Megan)PACER Document
Jun 11, 2025SO ORDERED, re 107 MOTION for Pro Hac Vice Appearance of Attorney Kevin Georgek and Samantha Kokonis, filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company, Bristol-Myers Squibb Company. Ordered by Judge Colm F. Connolly on 6/11/2025. (kmd)PACER Document
Jun 13, 2025CLAIM Construction Chart by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company. (Attachments: (1) Exhibits A-C)(Dellinger, Megan)PACER Document
Jun 13, 2025CLAIM Construction Chart by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company. (Attachments: (1) Exhibits A-C)(Dellinger, Megan)Attachment
Jun 13, 2025MOTION for Claim Construction re [109] Claim Construction Chart - filed by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company. (Dellinger, Megan)PACER Document
Jun 13, 2025MOTION for Claim Construction - filed by Natco Pharma Ltd.. (Metzler, Sara)PACER Document
Jun 19, 2025STIPULATION TO EXTEND TIME for Plaintiffs to produce documents to Apotex Inc., Apotex Corp., and Changzhou Pharmaceutical Factory pursuant to Paragraph 10(b) of the Scheduling Order (D.I. 25) with respect to U.S. Patent Nos. 8,314,117 and 8,759,372 to July 10, 2025 - filed by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company. (Dellinger, Megan)PACER Document
Jun 20, 2025SO ORDERED, re [112] STIPULATION TO EXTEND TIME for Plaintiffs to produce documents. Signed by Judge Colm F. Connolly on 6/20/2025. (mws)PACER Document
Jul 1, 2025NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company.(Dellinger, Megan)PACER Document
Jul 23, 2025Joint STIPULATION TO EXTEND TIME for Defendants to serve their Answering CC Brief to August 1, 2025 and for Plaintiffs to serve their Reply CC Brief to August 20, 2025 - filed by Natco Pharma Ltd.. (Metzler, Sara)PACER Document
Jul 23, 2025SO ORDERED, re [115] Joint STIPULATION TO EXTEND TIME for Defendants to serve their Answering CC Brief to August 1, 2025 and for Plaintiffs to serve their Reply CC Brief to August 20, 2025, filed by Natco Pharma Ltd. Reset Deadlines for Claim Construction Briefing and Markman Hearing: Claim Construction Answering Brief due by 8/1/2025. Claim Construction Reply Brief due by 8/20/2025. Signed by Judge Colm F. Connolly on 7/23/2025. (kmd)PACER Document
Aug 1, 2025NOTICE requesting Clerk to remove Joel L. Broussard as co-counsel. Reason for request: No longer with firm. (Dellinger, Megan)PACER Document
Aug 1, 2025NOTICE OF SERVICE of (1) Defendants' Answering Claim Construction Brief with Exhibits 13 and 14; and (2) Joint Claim Construction Brief (Redline) filed by Teva Pharmaceuticals, Inc..(Gellar, Lindsey)PACER Document